CTA

Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing

Retrieved on: 
Tuesday, January 16, 2024
Health, Medical Devices, Infectious Diseases, Genetics, General Health, Pharmaceutical, Biotechnology, Miami Beach Convention Center, Senior, CRL, CMC, Regulation, Patient, CTA, LVV, DNA, AAV, Education minister, GMP, Gene, Tecmar, IND, COA, Doctor of Philosophy, Investigational New Drug, RC2, Cell, CDMO, Commercialization, Plasmid, Pharmaceutical industry

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline adeno-associated virus (AAV)-based gene therapy programs.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline adeno-associated virus (AAV)-based gene therapy programs.
  • Charles River will officially launch the off-the-shelf Rep/Cap plasmid offering during Advanced Therapies Week , January 16-19, at the Miami Beach Convention Center.
  • Join Dr. Baghirzade in the Gene Therapy Manufacturing Track as part of the Regulatory Alignment for Gene Therapy Manufacturing session to learn how to:
    Ensure alignment with phase-appropriate plasmid DNA, AAV, and lentiviral vector (LVV) manufacturing best practices
    Matthew Hewitt, B.A.
  • Charles River has significantly broadened its cell and gene therapy portfolio with several acquisitions and capacity expansions to simplify complex supply chains and meet the growing global demand for plasmid DNA, viral vector, and cell therapy services.

CES 2024: The Global Platform Defining Our Future

Retrieved on: 
Saturday, January 13, 2024
Digital health, Nu Skin Enterprises, IPS, Artificial intelligence, Advertising, C space, Walmart, Mobility, Elevance Health, Human, D-NV, Assistant, Privacy, Consumer Technology Association, Policy, Health equity, UN, TFX, Recycling, Centennial, Transport, EssilorLuxottica, Investment, Marketing, Force, HD Hyundai, CTA, Generation Z, FCC, Tech, Innovation, AI, Therapy, CES, Content, Telehealth, Intel, FTC, ARIA, ALL, Treasury, Partnership, Ecosystem, All, CPSC, FDA, CMOS, Patient safety, Research, News, Universal design, Medical device

LAS VEGAS, Jan. 13, 2024 /PRNewswire/ -- CES® 2024 closes today, after an exhilarating week that set the technology narrative for the year ahead. With 4300+ exhibitors, including a record 1400+ startups from around the globe in Eureka Park®, CES showcased the innovative trends shaping tomorrow and solving the world's most pressing challenges.

Key Points: 
  • Across the show and on CES conference stages, thousands of global brands announced new visions, products, investments and partnerships," said Kinsey Fabrizio, CTA Sr. VP, CES and membership.
  • Artificial Intelligence – AI led the global conversation at CES 2024.
  • This week at CES, Force for Good released a new report at the CES Research Summit on tech's influence on human securities.
  • Mobility – With 600+ mobility exhibitors, CES is one of the world's largest and fastest growing global auto, mobility and transportation events.

CES 2024: The Global Platform Defining Our Future

Retrieved on: 
Saturday, January 13, 2024
Digital health, Nu Skin Enterprises, IPS, Artificial intelligence, Advertising, C space, Walmart, Mobility, Elevance Health, Human, D-NV, Assistant, Privacy, Consumer Technology Association, Policy, Health equity, UN, TFX, Recycling, Centennial, Transport, EssilorLuxottica, Investment, Marketing, Force, HD Hyundai, CTA, Generation Z, FCC, Tech, Innovation, AI, Therapy, CES, Content, Telehealth, Intel, FTC, ARIA, ALL, Treasury, Partnership, Ecosystem, All, CPSC, FDA, CMOS, Patient safety, Research, News, Universal design, Medical device

LAS VEGAS, Jan. 12, 2024 /PRNewswire/ -- CES® 2024 closes today, after an exhilarating week that set the technology narrative for the year ahead. With 4300+ exhibitors, including a record 1400+ startups from around the globe in Eureka Park®, CES showcased the innovative trends shaping tomorrow and solving the world's most pressing challenges.

Key Points: 
  • Across the show and on CES conference stages, thousands of global brands announced new visions, products, investments and partnerships," said Kinsey Fabrizio, CTA Sr. VP, CES and membership.
  • This week at CES, Force for Good released a new report at the CES Research Summit on tech's influence on human securities.
  • Mobility – With 600+ mobility exhibitors, CES is one of the world's largest and fastest growing global auto, mobility and transportation events.
  • Visit CES or the CES App , sponsored by Walmart, for keynotes, sessions and product announcements.

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

Retrieved on: 
Wednesday, January 10, 2024
Ageing, Patient, CTA, MHRA, Medication, Principal, MECP2, Health care, Rush University Medical Center, AAV, Female, Rett syndrome, European Commission, Orphan drug, Risk, Mutation, Disease, Safety, Central nervous system, Caregiver, Fast Track, FDA, Index, Neurology, Adolescence, MTD, CNS, Pharmaceutical industry

DALLAS, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), today announced that the first pediatric patient has been dosed with TSHA-102 in the REVEAL Phase 1/2 pediatric trial in the United States (U.S.) evaluating the safety and preliminary efficacy of TSHA-102 in stage three female patients 5-8 years of age with Rett syndrome. The Company also announced the United Kingdom (U.K.) Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the Clinical Trial Application (CTA) for TSHA-102 in pediatric patients, enabling expansion of the ongoing U.S. REVEAL pediatric trial into the U.K.

Key Points: 
  • Initiation of REVEAL pediatric trial in the U.S. broadens the clinical evaluation of TSHA-102 to female patients 5-8 years old with stage three Rett syndrome
    MHRA authorized the CTA for TSHA-102 in pediatric patients with Rett syndrome, enabling expansion of ongoing U.S.
  • “Dosing the first pediatric patient with Rett syndrome marks an important step forward in our efforts to broaden the clinical evaluation of TSHA-102 to younger patients with earlier stages of Rett syndrome.
  • “The pediatric trial will build on our ongoing REVEAL adolescent and adult trial, where early data demonstrated improvements across multiple clinical domains in adult patients with the most advanced stage of disease.
  • TSHA-102 is also being evaluated in the ongoing first-in-human REVEAL Phase 1/2 adolescent and adult trial in females aged 12 and older with Rett syndrome in Canada.

Biomea Fusion Highlights Recent Updates and Anticipated 2024 Corporate Milestones at 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 9, 2024
Diabetes, DSM-IV codes, Patient, Leukemia, CTA, PST, Research, CLL, Osteopathic medicine in Canada, Diagnosis, FLT3, NSCLC, Insulin, Cancer, IND, Conference, Safety, DLBCL, FDA, Glycated hemoglobin, PDAC, AML, CRC, Phase, Health Canada, Week, Pharmaceutical industry

Open label portion of Phase II COVALENT-112 study readout in 40 patients with type 1 diabetes expected in 2024.

Key Points: 
  • Open label portion of Phase II COVALENT-112 study readout in 40 patients with type 1 diabetes expected in 2024.
  • A live webcast of the presentation will be available on the Investors & Media page of Biomea’s website at: https://investors.biomeafusion.com/news-events/events .
  • “2023 was a truly remarkable year for Biomea as we had several positive data readouts in both type 2 diabetes and AML.
  • “We believe BMF-219 has the potential to address the root cause of diabetes and modify its progression in patients.

Mitsubishi Electric America Foundation Senior Director Kevin Webb Appointed to Consumer Technology Association Foundation Board

Retrieved on: 
Wednesday, January 10, 2024
Manufacturing, Environment, Autonomous Driving, Vehicles, Automotive, Human Resources, Artificial Intelligence, Environmental, Social and Governance (ESG), Consumer, Foundation, Professional Services, Consumer Electronics, Philanthropy, Technology, People with Disabilities, Recycling, Training, Chemicals, Plastics, Education, Artificial intelligence, Blue star, Consumer Technology Association, CTA, Sustainability, Social impact, Verizon Communications, Electronics, ESG, Plastic, CTAF, Head, Disability, Consumer Electronics Show, Mitsubishi Electric America Foundation, Electricity, CES, Workforce, Organization, News, Mitsubishi Electric, Mitsubishi Group

Mitsubishi Electric and Mitsubishi Electric America Foundation (MEAF) have announced that senior director Kevin Webb has been appointed to the Consumer Technology Association Foundation (CTA Foundation) board.

Key Points: 
  • Mitsubishi Electric and Mitsubishi Electric America Foundation (MEAF) have announced that senior director Kevin Webb has been appointed to the Consumer Technology Association Foundation (CTA Foundation) board.
  • The foundation is the non-profit arm of the Consumer Electronics Association (CTA) ®, which hosts the annual Consumer Electronics Show (CES) .
  • “CTAF’s mission to provide seniors and people with disabilities with technologies to enhance their lives aligns with Mitsubishi Electric’s purpose to realize a truly sustainable global smart society,” said Kevin Webb, senior director, Sustainability & Social Impact for Mitsubishi Electric, and head of MEAF.
  • Carla Gaouette, Vice President of James Emmett & Co., a disability employment consultant, will join Webb at Mitsubishi Electric’s booth.

Mitsubishi Electric Highlights Purpose and Core Strategy to Advance a Global, Vibrant and Sustainable Smart Society at CES 2024

Retrieved on: 
Tuesday, January 9, 2024
Software, Mobile, Wireless, Networks, Internet, Sustainability, Consumer Electronics, IOT (Internet of Things), Technology, Construction & Property, Environment, Semiconductor, Green Technology, Building Systems, Lidar, Consumer Technology Association, CTA, Temperature, Multimedia, Knowledge, Insurance, Smartphone, Kumo, Plastic, Ventilation, Carbon, Mitsubishi Electric United States, Consumer Electronics Show, Disability, Safety, Television, Mitsubishi Electric America Foundation, Transport, CES, Mitsubishi Electric, SPAN, Renewable energy

At this week’s Consumer Electronics Show (CES) in Las Vegas, Mitsubishi Electric will highlight its corporate purpose and core strategy to advance a global, vibrant and sustainable smart society.

Key Points: 
  • At this week’s Consumer Electronics Show (CES) in Las Vegas, Mitsubishi Electric will highlight its corporate purpose and core strategy to advance a global, vibrant and sustainable smart society.
  • View the full release here: https://www.businesswire.com/news/home/20240109912540/en/
    At this week’s Consumer Electronics Show (CES) in Las Vegas, Mitsubishi Electric will highlight its corporate purpose and core strategy to advance a global, vibrant and sustainable smart society.
  • By 2030, its goal is to reduce greenhouse gas emissions from company’s factories and offices by 100% or more.
  • LiveWire S2 Del Mar electric motorcycle spotlights how Mitsubishi Electric’s semiconductor products contribute to the world’s electrification and the future of transportation.

Incheon Mayor Yoo Jeong-bok Leaps for the Vision of 'Super First-Class Smart Hub City' at CES 2024

Retrieved on: 
Friday, January 12, 2024
Exhibition, CTA, HD, Consumer Technology Association, Las Vegas Convention Center, Multimedia, City, Incheon Free Economic Zone, Shinhan Bank, Electronics, AI, Transport law, ICT, Samsung Electronics, Future, Information technology, CES, Hyundai Motor Company, Shinhan Financial Group, LG Electronics

SEOUL, South Korea, Jan. 12, 2024 /PRNewswire/ -- A news report from AVING Global:

Key Points: 
  • -     Incheon Mayor Yoo unveiled the 'Super Smart Hub City' vision at CES 2024, promoted global collaboration, showcased AI solutions, and engaged with tech giants.
  • He is leading in the global promotion of the 'Super FirstClass Smart Hub City' and supporting the overseas expansion of Incheon startups.
  • The Incheon Free Economic Zone Authority announced that Mayor Yoo Jeong-bok participated in CES 2024 from January 9th to 12th, presenting Incheon's smart city future vision.
  • Incheon became the only local government from South Korea to exhibit in LVCC, the main exhibition hall for CES 2024.

Seoul Metropolitan Government hosts the largest-ever 'Seoul Pavilion' at CES 2024 with 18 innovation awards recipients

Retrieved on: 
Friday, January 12, 2024
Seed, Lighting, CTA, Met, Consumer Technology Association, Kyung Hee University, Multimedia, Konkuk University, Electronics, Seoul Metropolitan Government, Innovation, Yonsei University, ESG, Growth, Hanyang University, Sogang University, Chung-Ang University, Entrepreneurship, Toptable, ICT, CES 2020, COVID-19, CES, Organization, Kookmin University, Korea University

Seoul Metropolitan Government first participated in CES in 2020 with 20 companies and has been operating the to support investment promotion and sales of innovative companies based in Seoul.

Key Points: 
  • Seoul Metropolitan Government first participated in CES in 2020 with 20 companies and has been operating the to support investment promotion and sales of innovative companies based in Seoul.
  • The following COVID-19 pandemic halted face-to-face exchanges after CES 2020, but Seoul startups continued to expand their presence and fame.
  • This year, 2024, Seoul Pavilion featured a record-setting 81 exhibiting startups and 18 Innovation Award Winners.
  • Of the 81 companies participating in the Seoul Pavilion, 18 won the CES 2024 Innovation Awards.

ITRI's CES 2024 Showcase Leads Tech Trends, Highlighting Global Collaborations

Retrieved on: 
Friday, January 12, 2024
CTA, Market research, Golf, Facial recognition, Consumer Technology Association, Athlete, LED, AI, Sport, Love, EOI, Human, Robotics, CES, ITRI, ADATA, Retail

HSINCHU, Jan. 11, 2024 /PRNewswire/ -- At CES 2024, ITRI presented ten groundbreaking innovations spanning AI robotics, smart sports, digital health, and AI display and entertainment.

Key Points: 
  • HSINCHU, Jan. 11, 2024 /PRNewswire/ -- At CES 2024, ITRI presented ten groundbreaking innovations spanning AI robotics, smart sports, digital health, and AI display and entertainment.
  • The CES 2024 trends were predicted to be AI, sustainability, and inclusivity.
  • Through CES, ITRI is opening up even more collaboration opportunities, engaging with potential investors, and exploring tech licensing and ventures."
  • Notably, iGolfPutter has been named by Forbes Magazine as one of the technologies to look for at CES 2024.